As president of the BCBSNC Foundation, Colleen Briggs, MBA, reflects on 25 years of progress and outlines where the ...
Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...
Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
I read with great interest the recent article by Taylor et al published in The American Journal of Managed Care, which ...
Federal directives deploy priority review vouchers, earlier DEA rescheduling, and ARPA-H matching funds to compress ...
The US national crisis hotline, 988, was contacted over 18 million times since its launch in July of 2022; however, despite its necessity, many centers are struggling to recruit and retain staff and ...
As president of the BCBSNC Foundation, Colleen Briggs, MBA, reflects on 25 years of progress and outlines where the ...
ADAPT OCULUS trial, which found promising results for treating patients with ocular myasthenia gravis. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
Healthcare data’s high fraud utility and broad clinical dependencies make ransomware uniquely harmful, coupling identity ...
INSTI, Tenofovir-Free Regimen DOR/ISL Gains FDA Approval for HIV This fixed-dose, 2-drug combination is a once-daily, ...
Long-acting therapies could be key to engaging unsuppressed patients and closing persistent gaps in HIV care. Despite major ...
A key insight from VESALIUS-CV is how the timing of benefit differs between patients with and without established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results